Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacia launches new blood alcohol test:

This article was originally published in Clinica

Executive Summary

Pharmacia (Sweden) has launched its radio-immunoassay CDTect for the detection and measurement of alcohol in blood. The product is on sale in Germany, France and Scandinavia. Testing for biochemical markers enables more sophisticated analysis of alcohol use and dependency than conventional breath tests, says Dr Rolf Iffland in Arzte Zeitung. However, forensic medicine relies solely on traditional methods for diagnosis. Dr Iffland argues that traditional breath tests do not detect many drivers who are shown to be over the limit of alcohol consumption using CDTect. The product is also capable of differentiating between those who have consumed large quantities of alcohol on single occasions and those who habitually drink heavily.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093876

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel